Physician profile
Michel E Hanen-Smith
NPI 1326119223
$1,235.97
in general payments reported to CMS, 2019-2025
14 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $57.67 · 2021: $150 · 2022: $226 · 2023: $225 · 2024: $149 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $228.92 | 2019-2025 | Rocklatan, Total30, Tryptyr |
| Novartis Pharmaceuticals Corporation | $147.95 | 2019-2023 | |
| Coopervision INC. | $133.42 | 2020-2023 | Clariti Contact Lens |
| Oyster Point Pharma, INC. | $130.99 | 2022-2025 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Vision Care, INC. | $130.15 | 2021-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $101.70 | 2019-2024 | Cequa |
| Maculogix, INC. | $92.20 | 2019-2021 | |
| Menicon America INC | $67.67 | 2019 | |
| Alcon Research LLC | $53.66 | 2019 | |
| Dompe US, INC. | $47.98 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $34.49 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $24.35 | 2025 | Acthar |
| Harrow Eye, LLC | $23.10 | 2025 | Vevye |
| Abb Con-Cise Optical Group LLC | $19.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michel Hanen-Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.